Related Articles
Tamoxifen in the treatment of metastatic malignant melanoma: still a controversy? (Review).
RELATIONSHIP BETWEEN RESPONSE RATE AND MEDIAN SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF ONCONASE(R) WITH OTHER ANTICANCER AGENTS
Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway
INVITRO SYNERGISM BETWEEN A NOVEL AMPHIBIAN OOCYTIC RIBONUCLEASE (ONCONASE(R)) AND TAMOXIFEN, LOVASTATIN AND CISPLATIN, IN HUMAN OVCAR-3 OVARIAN-CARCINOMA CELL-LINE
Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells